Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00006151 |
The purpose of this study is to combine a smoke ending aid with behavioral treatment.
Condition | Intervention | Phase |
---|---|---|
Tobacco Use Disorder |
Behavioral: Behavioral Therapy |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Combining a Smoke Ending Aid With Behavioral Treatment |
Enrollment: | 260 |
Study Start Date: | May 1999 |
Study Completion Date: | February 2008 |
The prime objective of this Innovative Stage I A/B Behavioral Therapy Development Research project is to conduct a pilot study under randomized, double-blind, placebo controlled conditions, to provide preliminary estimation of the efficacy of a 6 week Accu Drop nicotine fading protocol used in conjunction with cigarette tapering to bring about termination of cigarette usage in moderate to heavy smokers (*15 cpd) who are interested in smoking cessation. Both the experimental and control groups in this study will receive six weeks of the manually driven behavioral treatment by experienced and trained therapists. The experimental group (N=30) will also be prescribed active Accu Drops (AD&C) while the control condition (N=30) will be prescribed placebo Accu Drops (PD&C) very similar in appearance, viscosity, and taste to active Accu Drops. Completion of the study protocol and smoking cessation rates at 1 week, 1 month, and 6 months post-treatment will be the prime measures of efficacy. The findings of this study will provide sufficient preliminary indication for the efficacy of the experimental treatment and its extended investigation in a Phase II study or for its nonefficacy.
Ages Eligible for Study: | 21 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Pennsylvania | |
University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104 6178 |
Principal Investigator: | Peter W Gariti, Ph.D. | University of Pennsylvania |
Responsible Party: | University of Pennsylvania ( Peter Gariti, Ph.D. ) |
Study ID Numbers: | NIDA-11645-1, R01-11645-1 |
Study First Received: | August 8, 2000 |
Last Updated: | October 27, 2008 |
ClinicalTrials.gov Identifier: | NCT00006151 |
Health Authority: | United States: Federal Government |
Smoking Mental Disorders Tobacco Use Disorder Substance-Related Disorders Disorders of Environmental Origin |